Varex Imaging discloses merger proxy supplements amid two lawsuits, 13 demand letters
Varex Imaging filed supplemental disclosures to its proxy statement for the proposed acquisition by Teledyne Technologies, in response to two shareholder complaints and 13 demand letters that claim the proxy is misleading. The company says the claims are without merit and that the supplements do not change the merger consideration or the timing of the October 28, 2026 special meeting, but the lawsuits seek to block the deal until more information is disclosed.
Key points
- Two complaints were filed in New York Supreme Court on October 6 and October 7, 2026, and seek to enjoin the merger; the company also received 13 demand letters, one with a draft complaint.
- The HSR Act waiting period is set to expire at 11:59 pm Eastern time on November 19, 2026, unless terminated early or extended.
- The UK National Security and Investment Act review period runs until November 18, 2026, after the notification was accepted on October 8, 2026.
- The special meeting of stockholders to vote on the merger is set for October 28, 2026, at 4:30 p.m. Mountain Time, and the board continues to recommend voting FOR the merger.
The filing
Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 22, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.